Browse the evidence

Dual and triple receptor agonists (e.g., tirzepatide, retatrutide, survodutide) demonstrate second-generation efficacy (≥15% weight loss) in clinical trials, offering expanded treatment options for obesity.

Newer medications like tirzepatide target multiple hormones (GLP-1 and GIP) to help you lose more weight than older drugs. Clinical trials show many people lose 15% or more of their body weight. These are taken once a week and are often used alongside lifestyle changes.

Combining GLP-1 receptor agonists with resistance and aerobic exercise training yields greater fat loss and better preservation of lean muscle mass compared to GLP-1 use alone.

If you are prescribed a GLP-1 medication for weight loss, do not rely on the drug alone. You must combine it with resistance and aerobic exercise. This combination is critical to ensure you lose fat rather than muscle, preserving your metabolic health and physical function.

A daily protein intake of approximately 1.6 grams per kilogram of body weight is recommended to spare lean body mass during weight loss induced by GLP-1 medications.

When losing weight on GLP-1s, aim to eat approximately 1.6 grams of protein for every kilogram of your body weight each day. This specific target helps protect your muscle mass from being lost along with the fat.

Tirzepatide, a dual GIP/GLP-1 receptor agonist administered once weekly, produces superior weight loss and glycemic control compared to semaglutide and dulaglutide in patients with type 2 diabetes and obesity.

For patients with T2DM or obesity, tirzepatide offers a potent once-weekly injection option that improves weight, blood sugar, and lipid profiles more effectively than some existing GLP-1 drugs. Due to potential gastrointestinal side effects, treatment should start at low doses and escalate slowly. Access may be limited by cost, requiring engagement with healthcare policymakers and insurers.

Remote delivery of a multicomponent weight management intervention (diet, physical activity, behavioral counseling) achieves clinically meaningful weight loss and maintenance in adults with intellectual disabilities, with 6-month weight loss superior to face-to-face home visits.

For adults with intellectual disabilities, remote weight management using video calls, diet apps, and fitness trackers is a viable and potentially superior alternative to in-person home visits. Success requires a supportive caregiver (study partner) and the use of simplified, pre-configured technology (iPads with specific apps). The intervention includes dietary guidance (Enhanced Stop Light Diet), physical activity goals, and monthly behavioral counseling, leading to significant weight loss and maintenance over 24 months.

Shortening inter-set rest intervals from 120 seconds to 60 seconds during resistance training increases cardiovascular, metabolic, and perceptual stress without reducing total volume-load, thereby providing a more potent stimulus for hypertrophy.

To maximize muscle growth, try reducing your rest between sets to 60 seconds. This increases the metabolic stress (lactate, heart rate, perceived effort) which is linked to hypertrophy, without sacrificing the amount of weight you lift. You do not need to rest 2 minutes; 1 minute is sufficient to maintain performance while boosting the hormonal and metabolic response.

In individuals with Type 2 Diabetes Mellitus, a 15-minute post-meal walk at ~60% VO2peak significantly reduces daily insulin exposure (AUC) and post-prandial glucose/insulin spikes, whereas an 8-hour time-restricted eating (TRE) window alone does not significantly alter total daily blood glucose compared to a 12-hour window.

If you have Type 2 Diabetes, focus on taking a 15-minute walk after your main meals rather than strictly restricting your eating window to 8 hours for immediate glucose control. This specific timing of light-to-moderate intensity walking significantly lowers insulin requirements and reduces post-meal blood sugar spikes, which helps manage daily glycemic variability.

Prescription weight loss medications (oral or injectable) combined with lifestyle interventions result in additional weight loss compared to lifestyle interventions alone, with newer emergent medications demonstrating up to 12.4% weight loss over 68 weeks.

If you have obesity, lifestyle changes are the foundation, but adding prescription medication can significantly boost your weight loss results (3-12%+). Don't let fear of needles or side effects stop you from discussing these options with your doctor; many patients find the benefits outweigh the manageable risks, and doctors often overestimate this fear.

Combining GLP-1 receptor agonists with resistance training and/or specific nutritional strategies (e.g., higher protein, ketogenic therapy) preserves fat-free mass and muscle strength better than pharmacotherapy alone.

To prevent muscle loss while on GLP-1s, consider combining your medication with resistance training and a diet that supports muscle retention, such as one higher in protein or potentially ketogenic, under medical supervision.

Obesity medications (OMs) such as semaglutide and tirzepatide cause significant weight loss but also result in lean mass loss, necessitating targeted nutritional and exercise interventions to preserve skeletal muscle.

OMs like semaglutide and tirzepatide are highly effective for weight loss but can cause muscle loss. To counter this, eat enough protein (0.8-1.5 g/kg/day depending on your age/health) and do resistance exercises. This helps protect your muscle while you lose fat.

In a comprehensive digital obesity service using Tirzepatide, consistent weekly behavioral engagement (weight tracking and health coach communication) is the strongest predictor of 12-month adherence and weight loss, whereas hyper-engagement (intensive tracking frequency and high initial weight loss velocity) in the first month significantly increases the risk of program attrition.

To maximize your chances of long-term success with Tirzepatide in a digital program, prioritize consistent, moderate engagement over intense, rapid efforts. Track your weight weekly and communicate regularly with your health coach. Avoid the trap of 'hyper-engagement'—such as tracking daily or expecting massive weight loss in the first month—as this is strongly linked to dropping out of the program. Sustainable habits beat short bursts of intensity.

A 3-month intervention combining alternate day fasting (600 kcal on fast days) and moderate-intensity aerobic exercise significantly reduces intrahepatic triglyceride content and associated cardiometabolic risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

For patients with fatty liver disease, a 3-month program of Alternate Day Fasting (eating 600 calories on fast days, normal on others) combined with 5 weekly sessions of moderate exercise (like brisk walking or cycling) significantly reduces liver fat. This approach is a validated, mainstay therapy that works by creating a caloric deficit and improving metabolic markers, even without drastic daily calorie counting.

High-intensity behavioral interventions involving at least 14 sessions over six months produce significant weight loss (5-10%) and improve glycemic control.

Structured behavioral programs are highly effective for weight loss, especially for those with type 2 diabetes. Committing to at least 14 sessions over six months can lead to a 5-10% reduction in body weight. These programs use techniques like self-monitoring and goal setting to improve adherence and health outcomes.

Semaglutide demonstrates the greatest mean reduction in body weight among GLP-1RAs in psychiatric populations, significantly outperforming placebo and showing superior efficacy to liraglutide and exenatide in network meta-analysis.

Among GLP-1 medications, semaglutide (oral) appears to produce the most significant weight loss in patients with psychiatric conditions, averaging over 6 kg (13 lbs) loss. It is more effective than liraglutide or exenatide in this group. However, data is limited to one study, so discuss availability and cost with your provider.

Intentional weight loss of 10% or more significantly improves cardiovascular outcomes, including arrhythmic free survival and symptom severity in atrial fibrillation, whereas lesser degrees of weight loss (e.g., 5%) do not show the same benefit.

If you have Atrial Fibrillation and are overweight, aim for a weight loss of at least 10% of your body weight. Small losses (like 5%) may not be enough to significantly improve your heart rhythm or symptoms. Consult your doctor for a structured weight loss plan.

Dual GLP-1R/GIPR agonists (e.g., tirzepatide) provide superior glycemic control and weight reduction compared to single-target incretin agonists.

If you have type 2 diabetes or obesity, dual-acting medications like tirzepatide may offer better weight loss and blood sugar control than older single-acting drugs. These are injectable medications that mimic gut hormones to reduce appetite and improve insulin function. Consult a doctor to see if this advanced therapy is appropriate for your specific health profile.

Weight loss of 7-10% of body weight improves the majority of histopathological features of NASH, including fibrosis, achieved through a daily calorie reduction of 500-1000 kcal combined with moderate-intensity exercise.

To improve liver health in NASH, aim to lose 7-10% of your body weight. This is best achieved by eating 500-1000 fewer calories per day and exercising moderately for 150 minutes a week. Even a 3-5% loss helps with liver fat, but the higher target is needed to reverse fibrosis.

Regular moderate exercise (150 minutes/week) provides hepatic and cardiometabolic benefits independent of weight loss.

Aim for 150 minutes of moderate exercise per week (e.g., brisk walking). This helps your liver and heart health directly, even if you don't lose weight.

Adherence to a Mediterranean diet, characterized by high intake of olive oil, vegetables, fruits, nuts, legumes, whole grains, fish, and seafood, with low intake of red and processed meat and reduced carbohydrates, offers cardiovascular benefits and is recommended for NAFLD management.

Eat a Mediterranean-style diet: lots of vegetables, fruits, nuts, legumes, whole grains, fish, and olive oil. Limit red and processed meat and keep carbohydrates to about 40% of your calories.

Protein supplementation combined with resistance training is the most prominent and effective intervention strategy for promoting muscle hypertrophy.

To maximize muscle growth, combine regular resistance training with adequate protein intake. This combination is the most widely supported strategy in current research. Ensure your training is progressive, as protein alone is not enough to overcome adaptation plateaus.

Supplementing pea protein with Lactiplantibacillus plantarum TWK10 (1x10^10 CFU) significantly increases the absorption of branched-chain, essential, and total amino acids compared to pea protein alone, leading to greater improvements in muscle thickness, strength, and anaerobic power in healthy adults undergoing resistance training.

If you are using pea protein for muscle building, adding Lactiplantibacillus plantarum TWK10 (10 billion CFU) to your daily 20g dose may significantly boost your muscle growth and strength gains. Take the mixture 30 minutes after resistance training or before bed for 4 weeks. This is particularly useful if you are vegetarian or vegan and want to maximize the benefits of plant-based protein.

Collagen supplementation significantly enhances fat-free mass and muscle strength gains in healthy adults undergoing resistance training, outperforming whey protein and other protein sources.

If you are doing resistance training, adding collagen supplements can significantly boost your muscle mass and strength gains, potentially more than whey protein. You don't need to rely solely on high-BCAA proteins; collagen's unique amino acids support muscle structure and recovery. Aim for a daily dose that fits your diet, as the study shows benefits across various dosages.

Whey protein supplementation significantly enhances muscle strength and fat-free mass gains compared to placebo, but is less effective than collagen.

Whey protein works for building muscle and strength, but the gains are smaller than those from collagen. If you are using whey, consider adding collagen to your regimen for potentially better results. Don't rely on whey alone if you want to maximize your strength and mass gains.

Intensive lifestyle interventions combining caloric restriction and moderate-intensity physical activity significantly reduce Obstructive Sleep Apnea (OSA) severity and can lead to remission in overweight or obese adults, with a linear dose-response relationship between weight loss magnitude and improvement in Apnea-Hypopnea Index (AHI).

If you have OSA and are overweight, losing weight is the most effective way to reduce its severity. Aim for a sustained weight loss of 10% or more through a combination of a reduced-calorie diet (1200-1800 kcal/day) and at least 175 minutes of moderate exercise per week. While CPAP is important, it doesn't fix the underlying obesity; combining it with these lifestyle changes offers the best chance for remission and long-term health.